樂純生物深耕(geng)生物制藥領域十(shi)余載(zai),廣泛服務于抗體、疫苗(miao)、細(xi)胞(bao)治療、基因治療、核酸類(lei)藥物等生物制藥企(qi)業。
樂純(chun)(chun)生(sheng)物(wu)(wu)(wu)(wu)專注于(yu)一(yi)次(ci)性工藝技術(shu)產品及(ji)解決(jue)方案,擁有多項生(sheng)物(wu)(wu)(wu)(wu)制(zhi)藥(yao)(yao)工藝一(yi)次(ci)性使用產品相關(guan)專利技術(shu),應用在生(sheng)物(wu)(wu)(wu)(wu)制(zhi)藥(yao)(yao)工藝中(zhong)(zhong)的(de)上(shang)游細(xi)胞培養、下游分離與純(chun)(chun)化(hua)以及(ji)最終制(zhi)劑(ji)灌(guan)裝等步(bu)驟,并伴(ban)隨生(sheng)物(wu)(wu)(wu)(wu)制(zhi)藥(yao)(yao)全(quan)生(sheng)命周期,貫穿研發、中(zhong)(zhong)試及(ji)商業化(hua)生(sheng)產階段;樂純(chun)(chun)生(sheng)物(wu)(wu)(wu)(wu)以技術(shu)創新(xin)為驅(qu)動(dong),引領一(yi)次(ci)性工藝技術(shu)快(kuai)速本土化(hua)的(de)進程,打通了上(shang)下游產業鏈(lian)為行業賦能。截(jie)至(zhi)2022年(nian)6月,樂純(chun)(chun)生(sheng)物(wu)(wu)(wu)(wu)在中(zhong)(zhong)國(guo)(guo)國(guo)(guo)內服(fu)務超過600家(jia)生(sheng)物(wu)(wu)(wu)(wu)制(zhi)藥(yao)(yao)企(qi)業,同時(shi)產品出口到秘魯、新(xin)加坡、韓國(guo)(guo)、德國(guo)(guo)等國(guo)(guo)家(jia),扎根(gen)中(zhong)(zhong)國(guo)(guo),服(fu)務全(quan)球。